Rabies was one of the first vaccine preventable diseases, yet it remains the world's most important zoonosis for reasons of financial disparity. Advances in rabies biologicals finally promise to make rabies prevention economically accessible to all. With improvements in survival during human rabies, we are increasing our understanding of the unique pathophysiology and immunology of this highly fatal viral encephalitis. Therapeutic animal models are under development and clinical trials will follow. As the science improves, we expect our findings to generalize to diagnostic and therapeutic approaches beneficial to other infectious neurological disorders.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
Future Virology. 2009;4(6):563-570. © 2009 Future Medicine Ltd.
Cite this: Are We Getting Closer to the Treatment of Rabies? - Medscape - Nov 01, 2009.